Use of population pharmacokinetic modeling to characterize intramuscular pharmacokinetics for ziprasidone in schizophrenic patients

M. U. Shad, S. H. Preskorn, J. Miceli, K. Wilner

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations

    Fingerprint

    Dive into the research topics of 'Use of population pharmacokinetic modeling to characterize intramuscular pharmacokinetics for ziprasidone in schizophrenic patients'. Together they form a unique fingerprint.

    Medicine & Life Sciences